Bank of New York Mellon’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.69M | Sell |
192,524
-5,653
| -3% | -$79K | ﹤0.01% | 2596 |
|
2025
Q1 | $2.67M | Buy |
198,177
+1,655
| +0.8% | +$22.3K | ﹤0.01% | 2537 |
|
2024
Q4 | $3.77M | Buy |
196,522
+25,692
| +15% | +$493K | ﹤0.01% | 2428 |
|
2024
Q3 | $3.89M | Sell |
170,830
-37,846
| -18% | -$861K | ﹤0.01% | 2414 |
|
2024
Q2 | $2.71M | Buy |
208,676
+56,814
| +37% | +$739K | ﹤0.01% | 2627 |
|
2024
Q1 | $2.66M | Buy |
151,862
+2,051
| +1% | +$35.9K | ﹤0.01% | 2622 |
|
2023
Q4 | $3.26M | Buy |
149,811
+11,634
| +8% | +$253K | ﹤0.01% | 2582 |
|
2023
Q3 | $2.12M | Sell |
138,177
-3,875
| -3% | -$59.4K | ﹤0.01% | 2773 |
|
2023
Q2 | $3.38M | Buy |
142,052
+2,417
| +2% | +$57.5K | ﹤0.01% | 2544 |
|
2023
Q1 | $3.55M | Sell |
139,635
-12,918
| -8% | -$329K | ﹤0.01% | 2486 |
|
2022
Q4 | $4.46M | Buy |
152,553
+62,290
| +69% | +$1.82M | ﹤0.01% | 2402 |
|
2022
Q3 | $1.85M | Buy |
90,263
+20,983
| +30% | +$430K | ﹤0.01% | 2908 |
|
2022
Q2 | $802K | Buy |
+69,280
| New | +$802K | ﹤0.01% | 3317 |
|
2019
Q4 | – | Sell |
-1,349
| Closed | -$15K | – | 4228 |
|
2019
Q3 | $15K | Sell |
1,349
-752
| -36% | -$8.36K | ﹤0.01% | 4188 |
|
2019
Q2 | $65K | Sell |
2,101
-4,805
| -70% | -$149K | ﹤0.01% | 4087 |
|
2019
Q1 | $289K | Buy |
6,906
+250
| +4% | +$10.5K | ﹤0.01% | 3749 |
|
2018
Q4 | $302K | Buy |
6,656
+2,473
| +59% | +$112K | ﹤0.01% | 3703 |
|
2018
Q3 | $350K | Buy |
4,183
+189
| +5% | +$15.8K | ﹤0.01% | 3773 |
|
2018
Q2 | $384K | Buy |
3,994
+1,638
| +70% | +$157K | ﹤0.01% | 3744 |
|
2018
Q1 | $248K | Sell |
2,356
-696
| -23% | -$73.3K | ﹤0.01% | 3847 |
|
2017
Q4 | $478K | Buy |
3,052
+1,225
| +67% | +$192K | ﹤0.01% | 3626 |
|
2017
Q3 | $250K | Sell |
1,827
-5
| -0.3% | -$684 | ﹤0.01% | 3816 |
|
2017
Q2 | $355K | Buy |
+1,832
| New | +$355K | ﹤0.01% | 3746 |
|